Chemical Structure (Sofosbuvir 01)
Sofosbuvir And Velpatasvir Tablet, Film Coated
Product Images NDC 72626-2701
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sofosbuvir And Velpatasvir (NDC 72626-2701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asegua Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Sofosbuvir 02)
Principal Display Panel (14 Tablet Blister Card Carton)
This is a medication called Sofosbuvir and Velpatasvir presented in the form of tablets. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir. The package comes with 28 tablets divided into two blisters cards with 14 tablets per blister card. It is an authorized generic of Epclusa. The medication should be taken once daily and should be stored below 30°C (86°F). The NDC number is 72626:27011. There is an alert against storing medicines that should NOT be kept with St and Velpatanis. There is also a warning to not cover the ALERT box with a pharmacy label. The medication is manufactured for Asegua Therapeutics LLC, an affiliate of Gilead Sciences, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
